Evaluation of a Personalizable Pessary for Pelvic Organ Prolapse

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Alberta

About this trial

Pelvic organ prolapse (POP) is a common health issue. It will impact about half of Canadian women over their lifetime. With POP, organs like the bladder, uterus, and bowel may push into the vagina. Women may experience urine leakage, physical discomfort, and embarrassment. Aside from surgery, a common treatment for POP is the use of pessaries. Pessaries are removable devices placed inside the vagina that can relieve POP symptoms. Unfortunately, pessaries have fixed sizes and three in ten patients cannot find the right fit. Pessaries can cause bleeding and discomfort if they do not fit well or are not removed and cleaned regularly. Almost half of patients who wear pessaries stop using them because of these issues. There is a need for a better pessary treatment for patients.

The investigators have developed a new pessary that has the natural shape of the vagina. This pessary is easier to remove and re-insert. The pessary is also custom fit for each patient. In this study, the investigators will compare our new pessary to traditional pessaries. Study participants who have been fit with a traditional pessary will be asked to use our new pessary design for 3 months. Study participants will fill out questionnaires about their POP symptoms. The investigators will also ask patients to provide their feedback on comfort and how easy it is to use the new pessary. This study could open up new possibilities for treating POP across Canada and around the world.

Eligibility criteria

Qualifiers

Patients assigned female at birth

At least 18 years old at time of screening

Patients with symptomatic POP using a pessary for ≥ 3 months

Capable of giving informed consent

Disqualifiers

Pregnancy

Short vaginal length (total vaginal length <5 cm) or subjective vaginal narrowing

Vaginal erosion due to current pessary

Presence of vesicovaginal fistula

Trial design

Treatments tested in this trial

  • Novel Personalizable Pessary

Treatment groups

43 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Alberta

Lead sponsor

Alberta Innovates Health Solutions

Collaborator

Cosm Medical

Collaborator